HeidelbergCement Purchase Controlling Share of Georgian Cement Producer

HeidelbergCement purchased a stake of 51% in the Georgian cement producer Kartuli Tsementi; this is the first investment of HeidelbergCement in the Caucasus region. Located in Rustavi, 50 km from the Georgian capital Tbilisi, Kartuli Tsementi operates a grinding facility with a capacity of 100,000 tonnes of cement per year. HeidelbergCement plans to extend the capacity of the plant up to 500,000 tonnes of cement by early 2008 and later to increase the production of cement up to 1 million tonnes.

Georgia is a strategically well located country with a big potential for growth. It is benefiting from transport of oil from neighbouring Azerbaijan and it is also a transit country between the Black Sea and the Caspian Sea. Therefore, further economic growth, large investments in infrastructural projects and a significant increase in cement consumption are expected. Together with Azerbaijan, the Caucasian market with 13 million inhabitants currently absorbs 3.3 million tonnes of cement and is expected to grow up to 5 million tonnes by 2010.

“We want to benefit from the growth potential of the Caucasian market”, said Dr. Bernd Scheifele, Chairman of the Managing Board of HeidelbergCement. “With this investment, we pursue consistently our growth strategy of further expanding in the countries of Eastern Europe and Central Asia and of building up a strong market position there. The market entry into Georgia is a further important step to build up a network in this region.” In November and December 2005 respectively, HeidelbergCement had acquired the cement companies Buchtarma Cement in Kazakhstan and Doncement in the Ukraine.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.